Sterile Compounding Cleanrooms and USP 797: Requirements and Design Guidelines

USP General Chapter <797> sets the rules for compounding sterile preparations in the United States — the practices and environment that keep injected, infused and inhaled sterile drugs free of microbes and contaminants. For anyone designing or running a compounding cleanroom, <797> is the document that decides the room's ISO class, its layout and its monitoring.

Edition check: USP <797> was substantially revised, and the revised chapter became effective on 1 November 2023. Among other changes, it replaced the old low-, medium- and high-risk levels with Category 1, 2 and 3. Always verify design decisions against the current official USP text and your state board of pharmacy requirements. This article summarises design principles; it is not a substitute for the standard.

What USP <797> covers

The chapter governs compounded sterile preparations (CSPs) across the whole workflow: personnel training and hygiene, the environment where compounding happens, the primary engineering control that protects the product, testing and release, and documentation. Its aim is simple to state and hard to achieve — make every compounded sterile dose safe to put into a patient.

Category 1, 2 and 3: what replaced low, medium and high risk

This is the change that catches people out. If your facility documents still use "low-risk", "medium-risk" or "high-risk" CSPs, they are written against a superseded edition.

The 2023 revision assigns CSPs to Category 1, 2 or 3 based on a different set of factors: the environment in which compounding occurs, the nature of the starting components, the processing method, whether sterility testing is performed, and the garbing requirements applied. Manipulation complexity alone no longer sets the category.

· Category 1 — compounded in an ISO Class 5 primary engineering control located in a segregated compounding area that is not required to be classified. Shortest beyond-use dates.

· Category 2 — compounded in a cleanroom suite: an ISO 5 PEC inside an ISO Class 7 buffer room, with an ISO Class 8 ante area. Longer beyond-use dates.

· Category 3 — compounded in a cleanroom suite with additional controls, including sterility and (where applicable) bacterial endotoxin testing. Longest beyond-use dates.

The practical consequence for designers is straightforward: the category you want to be able to compound is a facility decision, made before a single panel is ordered. Choosing Category 1 to avoid building a cleanroom suite caps your beyond-use dates permanently.

ISO class by zone

Airborne particle classes themselves are defined by ISO 14644-1. USP <797> applies those classes to pharmacy practice and adds the process, training and monitoring requirements that ISO does not cover.

Beyond-use dates by category

The chapter links environment and process to how long a compounded preparation may be used. Better-controlled environments and additional testing support longer beyond-use dates (BUDs); less controlled setups shorten them. This is where cleanroom design has a direct, quantifiable payoff: a well-built suite supports more flexible, longer-held preparations than a marginal one.

Verify before you design: BUDs are also limited by chemical stability, which may be shorter than the chapter defaults. Confirm the exact limits for your preparations against the current official USP text before committing to a facility model.

Primary engineering controls and airflow

The PEC is where protection happens. It delivers ISO 5 air, typically as unidirectional flow across the critical site, sweeping particles away from the open vial or syringe. The surrounding room's pressure cascade and airflow must support — not fight — the PEC, so that air always moves from cleaner to less clean and never back toward the product.

In practice, most PEC problems are room problems. A PEC sited in a traffic lane, under a supply diffuser, or next to a door that opens fifty times a shift will not hold unidirectional flow no matter how good the unit is.

Personnel, garbing and competency

People are the largest particle and microbe source in any cleanroom, so <797> puts real weight on gowning, hand hygiene and aseptic technique. The gowning path and ante area are designed to shed and contain that load before a compounder reaches the buffer area, and training is documented and repeated.

Competency is assessed on a schedule, and the cadence tightens with the category:

· Garbing competency with gloved fingertip sampling: at least every 6 months for Category 1 and 2, every 3 months for Category 3.

· Aseptic manipulation competency with media fill: at least every 6 months for Category 1 and 2, every 3 months for Category 3.

Good design makes the right behaviour the easy behaviour — but the people remain the control that no filter replaces.

Cleaning and disinfection

The 2023 revision tightened cleaning requirements in ways that affect both operations and surface specification:

· Only sterile cleaning agents may be used inside the primary engineering control.

· Sporicidal disinfectant must be applied at least monthly, and is mandatory for Category 3 compounding.

· Surfaces have to tolerate the agents actually in use, at the required contact times.

That last point is a procurement decision. A panel face that chalks, stains or delaminates under the disinfectant regimen will fail you long before the protocol does.

Environmental monitoring

A compounding room is not "qualified once and forgotten". USP <797> expects ongoing environmental monitoring — viable air and surface sampling — so that a drift toward contamination is caught before it reaches a patient. The frequency scales with category.

Frequency also increases after maintenance work or a contamination event. Establish baseline microbial levels and define action levels in advance, so an excursion triggers a known response rather than a debate.

Documentation and records

A compounding operation lives in its records: training files, batch and beyond-use documentation, environmental monitoring results, and the qualification of the room itself. The design should support this with accessible monitoring displays and a logical place for segregated compounding, but the discipline is procedural.

An inspector will read the records as much as inspect the room, so the two must tell the same story. A clean room backed by a thin file is a finding waiting to happen.

Hazardous drugs: the USP <800> overlap

When the compounded preparation is hazardous — chemotherapy being the common case — USP <800> joins the picture, adding requirements for personnel protection and containment that can change the room's pressure strategy and exhaust.

Designers must establish early whether a suite handles only non-hazardous CSPs or also hazardous drugs, because the two demand different airflow and containment logic. Retrofitting containment into a suite designed only for <797> is expensive and rarely elegant.

Design guidelines that satisfy USP <797>

· ISO 5 PEC with verified unidirectional airflow at the critical site.

· Buffer and ante areas classified and laid out per the current chapter and your target category.

· Positive pressure cascade from cleaner to less clean zones.

· Smooth, coved, cleanable walls, ceilings and floors that tolerate the disinfectant regimen.

· Logical personnel and material flows that minimise crossing.

· Documented monitoring, training and release procedures.

Common design mistakes

· Placing the PEC where room airflow disrupts its unidirectional flow.

· Skipping the ante area so gowning happens in a dirty transition.

· Surfaces that cannot be cleaned, or that trap contamination at joints.

· No monitoring plan, so microbial drift goes unseen.

· Designing to an outdated edition of the chapter — the single most expensive mistake on this list.

Troubleshooting a failing environmental trend

Even a well-designed suite can show a drifting microbial or particle trend. The response should be systematic, not panicked:

1. Confirm the data is real — instrument calibration and sampling error account for many scares.

2. Walk the cascade and airflow: a drifting pressure differential or disrupted unidirectional flow at the PEC is the usual physical cause.

3. Review people and process: a new compounder, a changed garbing step or a different product can introduce load.

4. Correct the root cause, then re-sample to confirm the trend reversed.

The cheapest failures to fix are the ones caught by trend review before they become excursions. A monitoring plan that someone actually reads turns a potential recall into a routine adjustment.

Designing for inspection readiness

The goal of good <797> design is not to survive an inspection by luck but to make the right answer the easy one. Clear zoning, visible monitoring, logical flows and a documentation set that matches the room mean an inspector finds exactly what they expect, where they expect it. Readiness is built in during design, not bolted on the week before a survey.

Scoping a compounding suite? Wiskind's bio-pharmaceutical cleanroom team scopes PEC surroundings, buffer and ante areas, surfaces and the pressure cascade against current USP <797> expectations — so the build is inspection-ready from the first drawing. Start with planning and design or talk to an engineer.

FAQ

What ISO class is required for sterile compounding?

The primary engineering control must provide ISO Class 5 air at the critical site. For Category 2 and 3 compounding, the surrounding buffer area is ISO Class 7 and the ante area ISO Class 8. For Category 1, the PEC is ISO 5 and the surrounding segregated compounding area is not required to be classified.

Is USP <797> the same as ISO 14644?

No. ISO 14644 defines how particle cleanliness classes are measured. USP <797> is the pharmacy practice chapter that applies those classes — plus process, training, monitoring and beyond-use dating — to compounded sterile preparations.

What happened to low-, medium- and high-risk CSPs?

They were removed. The 2023 revision, effective 1 November 2023, replaced them with Category 1, 2 and 3, defined by compounding environment, starting components, processing method, sterility testing and garbing rather than by manipulation complexity.

Does USP <800> change the cleanroom design?

Yes, when hazardous drugs are compounded. USP <800> adds containment and personnel-protection requirements that can change pressure strategy and exhaust — often inverting the pressure relationship used for non-hazardous CSPs.

How often does a compounding cleanroom need re-certification?

At least every six months is the commonly applied cadence for classified areas, plus re-certification after changes or adverse trends. Confirm the requirement for your category and your state board's expectations.

Key takeaways

· USP <797> governs compounded sterile preparations in the US; the current edition took effect 1 November 2023.

· Category 1, 2 and 3 replaced the old low/medium/high risk levels — and the category you choose is a facility decision.

· The PEC must deliver ISO 5 air at the critical exposure site; buffer and ante areas follow per category.

· Monitoring frequency, competency assessment and BUD all tighten as the category rises.

· Hazardous drugs bring USP <800> containment into the design, and it changes the pressure strategy.

Related reading:ISO 5 vs ISO 7: which class fits your process · What is an ISO 5 cleanroom? · Cleanroom airflow and pressure cascades · Regulatory and certification requirements for bio-pharma cleanrooms